Business Standard

Fredun Pharmaceuticals Share Price

Know More
BSENSE

918.15 123.15 (15.49%)

04:01 PM,13th Jun 2024
Stock not traded

BSE : 539730

NSE :

Sector : Health care

ISIN Code : INE194R01017

  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: 13-Jun-2024 | 04:01 PM IST

Market Cap (₹ Cr)

430

Turnover (₹ Cr)

0.47

Volume (Shares)

51,653

Face Value

10

52-WK High

1,249.00

52-WK High Date

01-Aug-2023

52-WK Low

650.00

52-WK Low Date

13-Mar-2024

All Time High

1,428.00

All Time High Date

07-Dec-2022

All Time Low

12.50

All Time Low Date

28-Mar-2016

Fredun Pharmaceuticals Ltd

Incorporated in 1987 as a private limited company Fredun Pharmaceuticals (FPL) was converted into a public limited company in Mar.'94. The Company was promoted by Nariman Medhora and Daulat N Medhora. The promoters initially established D N Pharma a proprietary firm for the manufacture and export of pharmaceutical formulations. Since 1993 D N Pharma's operations were phased out in order to switch over the business to FPL. The Company is well diversified in the business ranging from Formulations to Diagnostics to Consultancy. The Company has an unique range of products from niche formulations anti-diabetics to the latest antiretroviral and anti - Hypertensive products. It supplies finished f...
Read More

Fredun Pharmaceuticals Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

430

EPS - TTM (₹) [S]

33.35

P/E Ratio (X) [S]

3.54

Face Value (₹) 10
Latest Dividend (%)7.00
Latest Dividend Date 22-Sep-2023
Dividend Yield (%) -
Book Value Share (₹) [S]259.29
P/B Ratio (₹) [S]3.54

Funds Owning this Stock

Scheme Name Amount Invested (₹ Cr) No Of Shares Net Asset (%)

Research Reports

Date Broker Action Prices(₹) Report
Data Not Found

Stock Strength

Today's Low/High

796.05

934.00

Week Low/High

785.00

934.00

Month Low/High

724.95

934.00

Year Low/High

650.00

1,249.00

All time Low/High

12.50

1,428.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week14.65%%2.312.53%
1 Month12.98%%5.545.86%
3 Month34.39%%5.566.37%
6 Month7.32%%10.3811.82%
1 Year7.88%%21.6525.02%
3 Year115.48%%46.3848.10%

Company Info

Company Information

WTD & Joint Managing Director : Daulat N Medhora

Executive Director : Nariman B Medhora

Non-Exec. & Independent Dir. : Aspi N Raimalwala

Managing Director & CFO : Fredun N Medhora

Non-Exec. & Independent Dir. : Rohinton Kanga

Company Sec. & Compli. Officer : Jinkal Shah

Additional Director : Daisy Dsouza

Registered Office: 26 Manoj Industrial Premises, G D Ambedkar Marg Wadala,Mumbai,Maharashtra-400031 Ph: 91-22-40318111

Email:business@fredungroup.com

URL:http://www.fredungroup.com

FAQs about Fredun Pharmaceuticals Ltd

1. What's the Fredun Pharmaceuticals Ltd share price today?
Fredun Pharmaceuticals Ltd share price was Rs 918.15 at 04:01 PM IST on 13th Jun 2024. Fredun Pharmaceuticals Ltd share price was up by 15.49% over the previous closing price of Rs 795.00. Fredun Pharmaceuticals Ltd share price trend:

  • Last 1 Month: Fredun Pharmaceuticals Ltd share price moved up by 12.98% on BSE
  • Last 3 Months: Fredun Pharmaceuticals Ltd share price moved up by 34.39% on BSE
  • Last 12 Months: Fredun Pharmaceuticals Ltd share price moved up by 7.88% on BSE
  • Last 3 Years: Fredun Pharmaceuticals Ltd price moved up by 115.48% on BSE


2. How can I quickly analyse the performance of the Fredun Pharmaceuticals Ltd stock?
The performance of the Fredun Pharmaceuticals Ltd stock can be quickly analysed on the following metrics:

  • The stock's PE is 27.53
  • Price to book value ratio is 3.54
  • Dividend yield of 0.00
  • The EPS (trailing 12 months) of the Fredun Pharmaceuticals Ltd stock is Rs 33.35


3. What is the market cap of Fredun Pharmaceuticals Ltd?
Fredun Pharmaceuticals Ltd has a market capitalisation of Rs 430 crore.


4. What is Fredun Pharmaceuticals Ltd's 52-week high/low share price?
The Fredun Pharmaceuticals Ltd’s 52-week high share price is Rs 1,249.00 and 52-week low share price is Rs 650.00.


5. Is the Fredun Pharmaceuticals Ltd profitable?
On a consolidated basis, Fredun Pharmaceuticals Ltd reported a profit of Rs 5.06 crore on a total income of Rs 118.03 crore for the quarter ended 2024. For the year ended Mar 2024, Fredun Pharmaceuticals Ltd had posted a profit of Rs 5.06 crore on a total income of Rs 118.03 crore.


6. Which are Fredun Pharmaceuticals Ltd’s peers in the Health care sector?
Fredun Pharmaceuticals Ltd’s top 5 peers in the Health care sector are Zim Laboratories, Shukra Pharma., Titan Biotech, Fredun Pharma, Gennex Lab., Zenotech Lab., Jenburkt Pharma.


7. Who owns how much in Fredun Pharmaceuticals Ltd?
Key changes to the Fredun Pharmaceuticals Ltd shareholding are as follows:

  • Promoter holding in Fredun Pharmaceuticals Ltd has gone down to 48.92 per cent as of Apr 2024 from 49.16 per cent as of Dec 2023.